breakyl 800 mikrogramov
mylan ire healthcare limited, Írsko - fentanyl - 65 - analgetica - anodyna
breakyl 400 mikrogramov
mylan ire healthcare limited, Írsko - fentanyl - 65 - analgetica - anodyna
breakyl 600 mikrogramov
mylan ire healthcare limited, Írsko - fentanyl - 65 - analgetica - anodyna
breakyl 1200 mikrogramov
mylan ire healthcare limited, Írsko - fentanyl - 65 - analgetica - anodyna
ghryvelin (previously macimorelin aeterna zentaris)
atnahs pharma netherlands b.v. - macimorelin acetát - diagnostické techniky, Žliaz s vnútornou sekréciou - macimorelin - tento liek je určený len na diagnostické účely. ghryvelin is indicated for the diagnosis of growth hormone deficiency (ghd) in adults.
angiletta 2 mg / 0,03 mg
actavis group ptc ehf., island - chlórmadinón a etinylestradiol - 17 - anticoncipientia
daurismo
pfizer europe ma eeig - glasdegib maleate - leukémia, myeloidná, akútna - antineoplastické činidlá - daurismo is indicated, in combination with low-dose cytarabine, for the treatment of newly diagnosed de novo or secondary acute myeloid leukaemia (aml) in adult patients who are not candidates for standard induction chemotherapy.
ayvakyt
blueprint medicines (netherlands) b.v. - avapritinib - gastrointestinálne stromálne nádory - iné antineoplastické činidlá, protein kinase inhibítory - ayvakyt is indicated as monotherapy for the treatment of adult patients with unresectable or metastatic gastrointestinal stromal tumours (gist) harbouring the platelet-derived growth factor receptor alpha (pdgfra) d842v mutation.
tavneos
vifor fresenius medical care renal pharma france - avacopan - microscopic polyangiitis; wegener granulomatosis - imunosupresíva - tavneos, in combination with a rituximab or cyclophosphamide regimen, is indicated for the treatment of adult patients with severe, active granulomatosis with polyangiitis (gpa) or microscopic polyangiitis (mpa).
vydura
pfizer europe ma eeig - rimegepant - poruchy migrény - antimigraine preparations, calcitonin gene-related peptide (cgrp) antagonists - vydura is indicated for theacute treatment of migraine with or without aura in adults;preventative treatment of episodic migraine in adults who have at least 4 migraine attacks per month.